Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Steve Jackson, PharmD
Raghava Reddy Induru, MD
Optimizing Multidisciplinary Care in Perioperative NSCLC
David Tom Cooke, MD, FACS
Joshua Reuss, MD
Blood-Based Colorectal Cancer Screening: Where Do We Stand?
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Brian P. McDonough, MD, FAAFP
Bilal Siddiqui, MD
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Neil M. Iyengar, MD
Sarah H. Donahue, MPH, NP
Improving CRC Screening Workflows: A PCP's Recommendations
Natalia Usoltseva MD, FACP, MHA
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Petros Grivas, MD, PhD
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
Barbara O'Brien, MD
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
Nadia Harbeck, MD, PhD
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
Benjamin Levy, MD
Melin Khandekar, MD, PhD
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
Inside the Decision: Case-Based Navigation of Brain Metastases in Breast and Lung Cancer
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
How Colorectal Cancer Screening Fits into OB/GYN Care
Mallik Greene, PhD
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
Redefining First-Line Therapy in mCSPC: Applying Evidence in Practice
William Oh, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.